362 related articles for article (PubMed ID: 29496508)
1. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
2. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
3. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
4. The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry.
Komorita Y; Iwase M; Fujii H; Ide H; Ohkuma T; Jodai-Kitamura T; Sumi A; Yoshinari M; Nakamura U; Kitazono T
Diabetes Res Clin Pract; 2018 Dec; 146():202-210. PubMed ID: 30391334
[TBL] [Abstract][Full Text] [Related]
5. Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes.
Shin JY
Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1454-1462. PubMed ID: 35256230
[TBL] [Abstract][Full Text] [Related]
6. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
7. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
[TBL] [Abstract][Full Text] [Related]
8. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
[TBL] [Abstract][Full Text] [Related]
10. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
[TBL] [Abstract][Full Text] [Related]
11. Estimation of Muscle Mass Using Creatinine/Cystatin C Ratio in Japanese Community-Dwelling Older People.
Kusunoki H; Tabara Y; Tsuji S; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Igase M; Shinmura K
J Am Med Dir Assoc; 2022 May; 23(5):902.e21-902.e31. PubMed ID: 34437868
[TBL] [Abstract][Full Text] [Related]
12. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
[TBL] [Abstract][Full Text] [Related]
13. Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients.
Shiomi K; Saito C; Nagai K; Kosaki K; Kawamura T; Kaneko S; Kai H; Morito N; Usui J; Yanagi H; Yamagata K
Clin Exp Nephrol; 2021 Oct; 25(10):1079-1086. PubMed ID: 34342777
[TBL] [Abstract][Full Text] [Related]
14. Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia.
Kusunoki H; Tsuji S; Kusukawa T; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Shinmura K
Clin Exp Nephrol; 2021 Mar; 25(3):231-239. PubMed ID: 33090338
[TBL] [Abstract][Full Text] [Related]
15. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study.
Tabara Y; Kohara K; Okada Y; Ohyagi Y; Igase M
Clin Nutr; 2020 Jun; 39(6):1857-1862. PubMed ID: 31431305
[TBL] [Abstract][Full Text] [Related]
16. High brain natriuretic peptide is associated with sarcopenia in patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study.
Okamura T; Hashimoto Y; Miki A; Kaji A; Sakai R; Iwai K; Osaka T; Kitagawa N; Ushigome E; Hamaguchi M; Asano M; Yamazaki M; Fukui M
Endocr J; 2019 Apr; 66(4):369-377. PubMed ID: 31019148
[TBL] [Abstract][Full Text] [Related]
17. Serum creatinine-to-cystatin C ratio as an indicator of sarcopenia in hemodialysis patients.
Yajima T; Yajima K
Clin Nutr ESPEN; 2023 Aug; 56():200-206. PubMed ID: 37344074
[TBL] [Abstract][Full Text] [Related]
18. Novel equations incorporating the sarcopenia index based on serum creatinine and cystatin C to predict appendicular skeletal muscle mass in patients with nondialysis CKD.
Hsu BG; Wang CH; Lai YH; Kuo CH; Lin YL
Clin Nutr; 2024 Mar; 43(3):765-772. PubMed ID: 38335801
[TBL] [Abstract][Full Text] [Related]
19. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.
Kashani K; Sarvottam K; Pereira NL; Barreto EF; Kennedy CC
Clin Transplant; 2018 Mar; 32(3):e13182. PubMed ID: 29274246
[TBL] [Abstract][Full Text] [Related]
20. Cre/CysC ratio may predict muscle composition and is associated with glucose disposal ability and macrovascular disease in patients with type 2 diabetes.
Yang Q; Zhang M; Sun P; Li Y; Xu H; Wang K; Shen H; Ban B; Liu F
BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34732398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
